🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Sickle cell anemia (SCA) is an inherited red blood disorder. The kidneys ar...
Status
Recruiting
Location
University of Illinois Chicago, Sickle Cell Center
Start Date
2026-04-08
Trial ID
NCT07175051
Treatments Being Tested
Diabetes is the leading cause of chronic kidney disease (CKD) and end-stage...
Status
Unknown
Location
Multiple Locations
Start Date
2023-03
Trial ID
NCT05373004
Treatments Being Tested
We compared the cardioprotective effects of empagliflozin, an SGLT2 inhibit...
Status
Completed
Location
Rehab Hussein Werida
Start Date
2023-08-10
Trial ID
NCT06313008
Treatments Being Tested
The trial will be performed as an open-label, randomised, single-dose, two-...
Status
Completed
Location
SOUSEIKAI Sumida Hospital
Start Date
2016-07-15
Trial ID
NCT02815644
Treatments Being Tested
The current study aims to explore the clinical effects and mechanistics of ...
Status
Unknown
Location
VU University Medical Center
Start Date
2017-11-09
Trial ID
NCT03433248
Treatments Being Tested
The primary aim of this clinical trial is to Evaluate the Possible Efficacy...
Status
Not Yet Recruiting
Location
Outpatient Clinic of Internal Medicine, Rheumatology and Immunology Department, Mansoura University Hospital
Start Date
2024-10-15
Trial ID
NCT06641128
Treatments Being Tested
The objective of this trial is to assess the effect of empagliflozin on car...
Status
Completed
Location
John Radcliffe Hospital
Start Date
2018-03-01
Trial ID
NCT03332212
Treatments Being Tested
The hypothesis is that the SGLT-2 inhibitor empagliflozin reduces tissue so...
Status
Completed
Location
Clinical Research Center, Department of Nephrology and Hypertension, University of Erlangen-Nuremberg
Start Date
2017-07-01
Trial ID
NCT03128528
Treatments Being Tested
The purpose of this study is to evaluate efficacy of pioglitazone (PIO) ver...
Status
Recruiting
Location
Mayo Clinic
Start Date
2025-05-29
Trial ID
NCT06729996
Treatments Being Tested
Purpose: The overall hypothesis of the study is that the benefits attained...
Status
Completed
Location
Mount Sinai Heart - Icahn School of Medicine at Mount Sinai
Start Date
2018-05-21
Trial ID
NCT03485222
Treatments Being Tested